Unaudited Condensed Statements of Operations - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2026 |
|||
| Formation and operating expenses | $ 240,381 | $ 240,381 | ||
| TOTAL EXPENSES | (240,381) | (240,381) | ||
| OTHER INCOME | ||||
| Income earned on cash held in Trust | 656,771 | 656,771 | ||
| Change in fair value of overallotment option | 212,823 | 212,823 | ||
| Net income | 629,213 | 629,213 | ||
| TOTAL OTHER INCOME | 869,594 | 869,594 | ||
| Redeemable Shares Outstanding | ||||
| OTHER INCOME | ||||
| Change in fair value of overallotment option | $ 124,360 | $ 87,394 | ||
| Weighted average shares outstanding, basic | [1] | 7,583,516 | 3,725,967 | |
| Weighted average shares outstanding, diluted | [1] | 7,583,516 | 3,725,967 | |
| Basic net income (loss) per ordinary share | $ 0.08 | $ 0.17 | ||
| Diluted net income (loss) per ordinary share | $ 0.08 | $ 0.17 | ||
| Non-Redeemable Shares Outstanding | ||||
| OTHER INCOME | ||||
| Change in fair value of overallotment option | $ 88,463 | $ 125,429 | ||
| Weighted average shares outstanding, basic | 5,394,505 | 5,347,514 | ||
| Weighted average shares outstanding, diluted | 5,394,505 | 5,347,514 | ||
| Basic net income (loss) per ordinary share | $ (0) | $ (0) | ||
| Diluted net income (loss) per ordinary share | $ (0) | $ (0) | ||
| ||||
| X | ||||||||||
- Definition Amount of change in fair value of overallotment option. No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|